Metabolizing profile of the cytochrome pathway CYP2D6, CYP3A4 and the ABCB 1 transporter in Spanish patients affected by Gaucher disease

Almeida-Calpe, A; De Frutos, LL; Medrano-Engay, B; Garcia-Garcia, CB; Ribate, MP; Giraldo, P

Giraldo, P (corresponding author), Fdn Espanola Estudio & Terapeut Enfermedad Gauche, Zaragoza, Spain.

CHEMICO-BIOLOGICAL INTERACTIONS, 2021; 345 ():

Abstract

Several therapeutic options are available for type 1 Gaucher disease (GD1), including enzymatic replacement therapy (ERT) and substrate reduction ther......

Full Text Link